Beyond, Inc. (BYON)
(Delayed Data from NYSE)
$8.16 USD
-0.79 (-8.83%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $8.16 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BYON 8.16 -0.79(-8.83%)
Will BYON be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BYON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BYON
Wall Street Analysts Believe Beyond (BYON) Could Rally 57.32%: Here's is How to Trade
Has Amazon.com (AMZN) Outpaced Other Retail-Wholesale Stocks This Year?
BYON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Despite Fast-paced Momentum, Beyond (BYON) Is Still a Bargain Stock
Beyond (BYON) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Ideas feature highlights: OpenDoor Technologies, Krispy Kreme, Beyond, Kohls and Beyond Meat
Other News for BYON
Interesting BYON Put And Call Options For September 12th
Beyond (BYON) Stock Rating Reiterated by Needham Analyst | BYON Stock News
FDA recommends scheduling action for 7-OH opioid products
Beyond, Inc. outlines contingent value right dividend and Bitcoin reserve as core business stabilizes
Beyond, Inc. (BYON) Q2 2025 Earnings Call Transcript